VXRT is at support currently after multiple earnings calls showing improvements in company funding and positioning.
It is currently touching lows in a range of .52-.58 for the 6th time this year, if it is unable to break support again I personally believe this will break to the upside back over $1.
In the event it does breakdown below .50 (which can very well...
Vaxart's previous run after COVID ended with a .30c gap down on the daily early June 2023, even so, once reaching previous low it ran up again. It has also shown much more promising earnings since the gap down. They have also ditched the Covid program to focus on norovirus and prolong cash runway into Q4. There is a WHO summit at the end of this month with...
